Optiver Holding’s BioNTech BNTX Stock Holding History

Optiver Holding’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Buy	2,150 +2,108	+5,019%	+$198K	﹤0.01%	898
2026 Q1	$3.73K	Sell	42 -1,259	-97%	-$129K	﹤0.01%	1555
2025 Q4	$124K	Sell	1,301 -704	-35%	-$70.9K	﹤0.01%	788
2025 Q3	$198K	Buy	+2,005	New	+$214K	﹤0.01%	622
2024 Q2	–	Sell	-14	Closed	-$1.29K	–	909
2024 Q1	$1.29K	Sell	14 -7	-33%	-$671	﹤0.01%	662
2023 Q4	$2.22K	Sell	21 -11	-34%	-$1.11K	﹤0.01%	472
2023 Q3	$3.48K	Buy	+32	New	+$3.54K	﹤0.01%	515

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Optiver Holding's BNTX Position: Q2 2026 in Review

Optiver Holding increased its BioNTech (BNTX) stake by 5,019% in Q2 2026, buying an estimated $198K and bringing the position to 2,150 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

Optiver Holding first reported a position in BNTX in Q3 2023 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Optiver Holding held 2,150 shares of BioNTech worth $200K as of Q2 2026.
Optiver Holding bought 2,108 BioNTech shares in Q2 2026, an estimated $198K.
BioNTech made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #898 holding.
Optiver Holding first reported a position in BioNTech in Q3 2023 and has held it in 7 quarters since.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.